Isox-Cha-Chg-ARK(Sulfo-Cy5)-NH2
Isox-Cha-Chg-ARK(Sulfo-Cy5)-NH2
| SMILES | C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC1CCCCC1)NC(=O)c1ccno1)c1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCNC(=O)CCCCC[N+]1=C(/C=C/C=C/C=C2/N(C)c3ccc(S(=O)(=O)[O-])cc3C2(C)C)C(C)(C)c2cc(S(=O)(=O)[O-])ccc21)C(N)=O |
| InChIKey | VXLISXCVTHKWNE-XZFSOASESA-M |
| Sequence | None |
Chemical Properties
| Hydrogen bond acceptors | None |
| Hydrogen bond donors | None |
| Rotatable bonds | None |
| Molecular weight (Da) |
Database connections
No bioactivity data available.
Isox-Cha-Chg-ARK(Sulfo-Cy5)-NH2
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
Phase II
Phase III
Phase IV